Japanese scientists have developed ADRIANA, a non-opioid painkiller that could provide powerful relief without the dangers of addiction. With successful trials already completed, large U.S. studies ...

Intravenous (IV) fosfomycin-based combination therapy was safe and well tolerated in high-risk paediatric patients (aged 0-18 years) with multidrug-resistant (MDR) infections, with minimal adverse ...

An investigational benzamide antipsychotic significantly improved symptoms in hospitalized adults with acute schizophrenia in a phase II trial. The drug, N-methyl amisulpride, is similar to its ...

KALAMAZOO, Mich. — The Kalamazoo Promise announced on Wednesday that eligible students attending community college will now receive 100% of their tuition as opposed to the previously instituted ...

An experimental drug from Spyre Therapeutics helped lower signs of disease activity and improve remission rates in a Phase 2 study of people with ulcerative colitis. After 12 weeks of treatment, ...

As the war with Iran rattles global energy markets and climate change drives the need for cleaner power, solar advocates are pointing to a fast-moving technology they believe could reshape the ...

INDIANAPOLIS – In a city where the face of homelessness is often misunderstood, one local organization has spent over three decades ensuring that a housing crisis doesn’t mean a broken family. Since ...

A prospective vaccine could offer future protection against Lyme disease. Pharmaceutical companies Pfizer and Valneva said their vaccine candidate was more than 70% effective at preventing Lyme ...

Policymakers and families should scrutinize proposals to adopt artificial intelligence in education, especially when those proposals rely on for-profit educational technology platforms. When powerful ...

Janus kinase (JAK) inhibitors are a promising and new method of treating alopecia areata, giving doctors new options for treating their patients, said Maria Hordinsky, MD, professor of dermatology at ...